Deutsche Bank AG Acquires 97,071 Shares of Humana Inc. (NYSE:HUM)

Deutsche Bank AG lifted its stake in Humana Inc. (NYSE:HUM) by 18.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 631,371 shares of the insurance provider’s stock after acquiring an additional 97,071 shares during the quarter. Deutsche Bank AG owned approximately 0.52% of Humana worth $160,185,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Dodge & Cox boosted its holdings in shares of Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after acquiring an additional 1,751,857 shares during the period. Norges Bank acquired a new position in shares of Humana during the 4th quarter worth about $416,202,000. Pzena Investment Management LLC raised its holdings in shares of Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the period. Finally, Boston Partners lifted its stake in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM stock opened at $249.67 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a fifty day simple moving average of $265.21 and a 200 day simple moving average of $270.30. The company has a market cap of $30.13 billion, a P/E ratio of 25.09, a P/E/G ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating analysts’ consensus estimates of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company posted $7.23 EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Friday, June 27th. Humana’s payout ratio is 25.04%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HUM shares. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Thursday, May 1st. StockNews.com raised Humana from a “hold” rating to a “buy” rating in a report on Friday. Robert W. Baird increased their price objective on shares of Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a research report on Tuesday, April 15th. Barclays lifted their target price on shares of Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a report on Friday, April 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus price target of $287.76.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.